Jefferies Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-16,800
Closed -$162K – 2035
2022
Q2
$162K Buy
+16,800
New +$211K ﹤0.01% 1306
2021
Q4
– Sell
-8,000
Closed -$130K – 2110
2021
Q3
$130K Buy
+8,000
New +$87.1K ﹤0.01% 1521
2017
Q1
– Sell
-200
Closed -$1K – 2731
2016
Q4
$1K Sell
200
-13,300
-99% -$395K ﹤0.01% 2176
2016
Q3
$623K Buy
+13,500
New +$761K ﹤0.01% 1514

Other funds holding ISEE

Jefferies Group's ISEE Position: Q3 2022 in Review

Jefferies Group increased its IVERIC bio, Inc. Common Stock (ISEE) stake by 2,861% in Q3 2022, buying an estimated $247K and bringing the position to 19,510 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #1174.

Jefferies Group first reported a position in ISEE in Q2 2015 and has held it in 8 quarters since. The position peaked at $1.58M in Q2 2021. 213 funds tracked by Wall St. Rank hold ISEE as of Q3 2022.

  • Jefferies Group held 19,510 shares of IVERIC bio, Inc. Common Stock worth $350K as of Q3 2022.
  • Jefferies Group bought 18,851 IVERIC bio, Inc. Common Stock shares in Q3 2022, an estimated $247K.
  • IVERIC bio, Inc. Common Stock made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1174 holding.
  • Jefferies Group first reported a position in IVERIC bio, Inc. Common Stock in Q2 2015 and has held it in 8 quarters since.
  • Jefferies Group's IVERIC bio, Inc. Common Stock position peaked at $1.58M in Q2 2021.
  • 213 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.